Literature DB >> 11358501

Differential recognition of epitopes present on monomeric and oligomeric forms of gp160 glycoprotein of human immunodeficiency virus type 1 by human monoclonal antibodies.

G Zeder-Lutz1, J Hoebeke, M H Van Regenmortel.   

Abstract

The mechanism of infectivity neutralization of human immunodeficiency virus type 1 (HIV-1) by Ig is poorly understood. Three human monoclonal antibodies (mAbs 1b12, 2G12 and 2F5) that are able to neutralize primary isolates of HIV-1 in vitro have been shown to act synergistically. In the present study this synergy was analyzed by measuring the epitope accessibility and binding kinetics for these three mAbs with respect to monomeric and oligomeric env protein gp160 IIIB using surface plasmon resonance. The results indicate that oligomerization of gp160 affects the accessibility of some of the epitopes recognized by the mAbs and provide some insight into the mechanism of synergy between different anti-(HIV-1) mAbs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11358501     DOI: 10.1046/j.1432-1327.2001.02167.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  7 in total

1.  Reductionism and complexity in molecular biology. Scientists now have the tools to unravel biological and overcome the limitations of reductionism.

Authors:  Marc H V Van Regenmortel
Journal:  EMBO Rep       Date:  2004-11       Impact factor: 8.807

2.  Time frames for neutralization during the human immunodeficiency virus type 1 entry phase, as monitored in synchronously infected cell cultures.

Authors:  Hillel Haim; Israel Steiner; Amos Panet
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

3.  Neutralization synergy of human immunodeficiency virus type 1 primary isolates by cocktails of broadly neutralizing antibodies.

Authors:  M B Zwick; M Wang; P Poignard; G Stiegler; H Katinger; D R Burton; P W Parren
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

4.  Oligomeric and conformational properties of a proteolytically mature, disulfide-stabilized human immunodeficiency virus type 1 gp140 envelope glycoprotein.

Authors:  Norbert Schülke; Mika S Vesanen; Rogier W Sanders; Ping Zhu; Min Lu; Deborah J Anselma; Anthony R Villa; Paul W H I Parren; James M Binley; Kenneth H Roux; Paul J Maddon; John P Moore; William C Olson
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

5.  Antigenicity and immunogenicity of transmitted/founder, consensus, and chronic envelope glycoproteins of human immunodeficiency virus type 1.

Authors:  Hua-Xin Liao; Chun-Yen Tsao; S Munir Alam; Mark Muldoon; Nathan Vandergrift; Ben-Jiang Ma; Xiaozhi Lu; Laura L Sutherland; Richard M Scearce; Cindy Bowman; Robert Parks; Haiyan Chen; Julie H Blinn; Alan Lapedes; Sydeaka Watson; Shi-Mao Xia; Andrew Foulger; Beatrice H Hahn; George M Shaw; Ron Swanstrom; David C Montefiori; Feng Gao; Barton F Haynes; Bette Korber
Journal:  J Virol       Date:  2013-01-30       Impact factor: 5.103

6.  Differential binding of neutralizing and non-neutralizing antibodies to native-like soluble HIV-1 Env trimers, uncleaved Env proteins, and monomeric subunits.

Authors:  Anila Yasmeen; Rajesh Ringe; Ronald Derking; Albert Cupo; Jean-Philippe Julien; Dennis R Burton; Andrew B Ward; Ian A Wilson; Rogier W Sanders; John P Moore; Per Johan Klasse
Journal:  Retrovirology       Date:  2014-05-29       Impact factor: 4.602

7.  Comparison of motif-based and whole-unique-sequence-based analyses of phage display library datasets generated by biopanning of anti-Borrelia burgdorferi immune sera.

Authors:  Yurij Ionov; Artem S Rogovskyy
Journal:  PLoS One       Date:  2020-01-15       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.